novel agents in nhl, fda approval in myeloma, combination trials with atezolizumab, and more
Published 8 years ago • 173 plays • Length 6:50
Download video MP4
Download video MP3
Similar videos
-
5:55
fda approval in myeloma, breakthrough designations in rcc and aplastic anemia, and more
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
11:50
fda approval in myeloma, priority review in dlbcl, application accepted of a biosimilar, and more
-
12:53
fda approval in sclc, partial hold in myeloma trials, nccn guideline update in crc, and more
-
6:27
fda approval in nsclc, and ema regulatory advances in pancreatic cancer, nhl, and cll
-
9:20
how to research literary agents
-
5:18
mpnst
-
1:00:32
understanding the fda approved new drug, selinexor and its use in multiple myeloma
-
11:25
novel agents for multiple myeloma
-
47:17
new directions in treating multiple myeloma in the era of novel agents
-
9:45
fda approval of a biosimilar, promising data in myeloma and gbm, and more
-
10:08
fda approval in waldenstrom macroglobulinemia, priority review and snda in myeloma, and more
-
1:27
dr. somlo on novel agents in multiple myeloma
-
9:02
fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
-
36:05
using novel therapeutic agents in early treatment for relapsed and refractory multiple myeloma
-
10:35
fda approval in aml, nda submitted in myeloma, clinical hold on car t-cell therapy trials, and more
-
9:41
asco's cancer advance of the year, fda approval in nets, and more
-
4:11
novel agents with len-dex
-
3:24
novel agents for the management of r/r myeloma
-
8:00
fda approval in rcc, european approvals in myeloma and melanoma, and 2016 aua highlights
-
6:27
fda approval in myeloma, priority review in all, and 2017 gu cancers symposium highlights
-
1:07
fda approval of frontline daratumumab plus vmp in multiple myeloma
Clip.africa.com - Privacy-policy